Interleukin-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma
Abstract
Details
- Title: Subtitle
- Interleukin-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma
- Creators
- Fabian Bick - Cancer Research Institute GhentClaudia M. Brenis Gómez - VIB-UGent Center for Inflammation ResearchInés Lammens - VIB-UGent Center for Inflammation ResearchJustine Van Moorleghem - VIB-UGent Center for Inflammation ResearchCaroline De Wolf - VIB-UGent Center for Inflammation ResearchSam Dupont - VIB-UGent Center for Inflammation ResearchLaure Dumoutier - de Duve InstituteNeal P. Smith - Massachusetts General HospitalAlexandra-Chloé Villani - Harvard Medical SchoolRobin Browaeys - Ghent UniversityJehan Alladina - Massachusetts General HospitalAlexis M. Haring - Harvard UniversityBenjamin D. Medoff - Massachusetts General HospitalJosalyn L. Cho - University of IowaRené Bigirimana - Ablynx (Belgium)Joao Vieira - Ablynx (Belgium)Hamida Hammad - VIB-UGent Center for Inflammation ResearchChristophe Blanchetot - Argenx (Belgium)Martijn J. Schuijs - Cancer Research Institute GhentBart N. Lambrecht - VIB-UGent Center for Inflammation Research
- Resource Type
- Journal article
- Publication Details
- Journal of allergy and clinical immunology, Vol.154(5), pp.1129-1145
- DOI
- 10.1016/j.jaci.2024.07.024
- PMID
- 39147327
- PMCID
- PMC12255943
- NLM abbreviation
- J Allergy Clin Immunol
- ISSN
- 0091-6749
- eISSN
- 1097-6825
- Publisher
- Elsevier Inc
- Grant note
- Baekeland Mandate of Flanders Innovation & Entrepreneurship (VLAIO): HBC.2019.2598 European Research Council (ERC): 789384 Ghent University (GOA): 01G010C9 Fonds Wetenschappelijk Onderzoek (FWO) Methusalem grant: 01M01521 FWO Excellence of Science (EOS) Consortium research grant: 3G0H1222 Flanders Institute of Biotechnology (VIB)FWO EOS Consortium research grant: 3G0H1222 FWO Vlaanderen: 12Y5322N Fund Suzanne DuchesneFondation ACTERIA
This work was funded by a Baekeland Mandate of Flanders Innovation & Entrepreneurship (VLAIO) (HBC.2019.2598) to F.B. B.N.L. acknowledges support from a European Research Council (ERC) advanced grant (789384 ASTHMA CRYSTAL CLEAR), a concerted research initiative grant from Ghent University (GOA, 01G010C9), a Fonds Wetenschappelijk Onderzoek (FWO) Methusalem grant (01M01521) and an FWO Excellence of Science (EOS) Consortium research grant (3G0H1222), and the Flanders Institute of Biotechnology (VIB) . H.H. is supported by a concerted research initiative grant from Ghent University (GOA, 01G010C9) and FWO EOS Consortium research grant (3G0H1222) . M.J.S. acknowledges support from FWO Vlaanderen (12Y5322N), Fund Suzanne Duchesne (managed by the King Baudouin Foundation), and Fondation ACTERIA.
- Language
- English
- Electronic publication date
- 08/13/2024
- Date published
- 11/2024
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Internal Medicine
- Record Identifier
- 9984696788702771